-+ 0.00%
-+ 0.00%
-+ 0.00%

Evogene Earnings Review: Q4 Summary

Benzinga·03/05/2026 12:10:35
Listen to the news

Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 5, 2026 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Evogene missed estimated earnings by -134.62%, reporting an EPS of $-0.61 versus an estimate of $-0.26.

Revenue was down $1.30 million from the same period last year.

Earnings History Overview

Last quarter the company beat on EPS by $0.1 which was followed by a 4.63% increase in the share price the next day.

Here's a look at Evogene's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.41 -0.63 -0.50 -0.73
EPS Actual -0.31 -0.50 -0.38 0.06
Revenue Estimate 650K 930K 4.42M 3.62M
Revenue Actual 312K 884K 2.44M 1.61M

To track all earnings releases for Evogene visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.